The Diagnostic Accuracy of Transient Elastography for the Diagnosis of Liver Fibrosis in Bariatric Surgery Candidates with Suspected NAFLD

Obesity Surgery

Volumn 24, Issue 10, 2014, Pages 1693-1701

  Naveau, Sylvie ^a,b,c   Lamouri, Karima ^a   Pourcher, Guillaume ^a   Njiké Nakseu, Micheline ^a   Ferretti, Stefano ^a   Courie, Rodi ^a   Tranchart, Hadrien ^a   Ghinoiu, Mariana ^a,b   Balian, Axel ^a   Prévot, Sophie ^a,b   Perlemuter, Gabriel ^a,b,c   Dagher, Ibrahim ^a,b  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Universite Paris Sud   (France)

Author keywords

Bariatric surgery; Liver fibrosis; Nonalcoholic fatty liver disease; Noninvasive test; Severe obesity; Transient elastography

Indexed keywords

ADULT; BARIATRIC SURGERY; BIOPSY; BODY MASS; CLINICAL TRIAL; COMPLICATION; ELASTOGRAPHY; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; PATHOLOGY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC;

ADULT; BARIATRIC SURGERY; BIOPSY; BODY MASS INDEX; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 84937538751     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-014-1235-9     Document Type: Article

References (27)

1. Chalasani N, Younossi Z, Lavine J, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, the American Gastroenterological Association. Hepatology. 2012;55:2005–23.
2. Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51:454–62.
3. De Ledinghen V, Vergniol J, Foucher J, et al. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int. 2010;30:1043–8.
4. Myers RP, Pomier-Layrargues G, Kirsch R, et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology. 2012;55:199–208.
5. Boursier J, Zarski JP, De Ledinghen V, et al. The Multicentric Group from ANRS/HC/EP23 FIBROSTAR Studies determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013;57:1182–91.
6. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.
7. Bedossa P, Poitou C, Veyrie N, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56:1751–9.
8. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a non parametric approach. Biometrics. 1988;44:837–45.
9. Zhou X, Obuchowski N, McClish D. Statistical methods in diagnostic medicine. New York: Wiley; 2002.
10. Obuchowski NA, Goske MJ, Applegate KE. Assessing physicians' accuracy in diagnosing paediatric patients with acute abdominal pain: measuring accuracy for multiple diseases. Stat Med. 2001;20:3261–78.
11. Lambert J, Halfon P, Penaranda G, et al. How to measure the diagnostic accuracy of noninvasive liver fibrosis indices the area under the ROC curve revisited. Clin Chem. 2008;54:1372–8.
12. Hintze JL. NCSS 2007 User Guide. Number Cruncher Statistical Systems 2007 software NCSS, Kaysville, UT, 2007.
13. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2009. ISBN 3-900051-07-0, URL http:// www.R-project.org.
14. Wai-Sun Wong V, Vergniol J, Lai-Hung Wong G, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2012;107:1862–71.
15. de Ledinghen V, Wong VW, Vergniol J, et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. J Hepatol. 2012;56:833–9.
16. Brunt ME. Histopathology of non-alcoholic fatty liver disease. Clin Liver Dis. 2009;13:533–44.
17. Dixon JB, Bhathal PS, O'Brien PE. Non alcoholic fatty liver disease: predictors of non alcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001: 91–100.
18. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274–85.
19. Ratziu V, Marchesini G, Romero-Gomez M, et al. The HOMA index is a useful tool for risk stratification of advanced fibrotic disease in a large cohort of European NAFLD patients. J Hepatol. 2013;58(supplement 1):S548–9.
20. Cournane S, Browne JE, Fagan AJ. The effects of fatty deposits on the accuracy of the Fibroscan® liver transient elastography ultrasound system. Phys Med Biol. 2012;57:3901–14.
21. Ziol M, Kettaneh A, Ganne-Carrié N, et al. Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis. Eur J Gastroenterol Hepatol. 2009;21:1261–8.
22. De Ledinghen V, Vergniol J, Foucher J, et al. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012;32:911–8.
23. Ong JP, Elariny H, Collantes R, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg. 2005;15:310–5.
24. Mathurin P, Gonzalez F, Kerdraon O, et al. The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology. 2006;130:1617–24.
25. Aron-Wisnewsky J, Minville C, Tordjman J, et al. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol. 2012;56:225–33.
26. Merriman RB, Ferrell LD, Patti MG, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology. 2006;44:874–80.
27. Boursier J, Calès P. Clinical interpretation of Fibroscan® results: a real challenge. Liver Int. 2010;30:1400–2.